» Articles » PMID: 10076907

The SCID/Beige Mouse As a Model to Investigate Protection Against Yersinia Pestis

Overview
Date 1999 Mar 17
PMID 10076907
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we have shown that severe combined immunodeficient/beige mice reconstituted with hyperimmune Balb/c lymphocytes can be used as a model to demonstrate adoptive and passive protection against plague infection. Reconstitution of severe combined immunodeficient/beige mice was successful in nine out of ten mice as demonstrated by spleen colonisation and sustained circulating immunoglobulin titres. Furthermore, an increase in antibody titre was evident after a booster immunisation of reconstituted mice. Presence of circulating antibody correlated with protection against a systemic plague challenge and indicated that in reconstituted mice adoptive transfer of a functional immune system had occurred. The severe combined immunodeficient/beige mouse was also used to demonstrate passive protection against inhaled and systemic plague infection. The reconstituted severe combined immunodeficient/beige mouse model demonstrating protective immunity against plague will be further developed to identify the immune cell subsets responsible for this protection.

Citing Articles

Chedíak-Higashi Syndrome: Hair-to-toe spectrum.

Greene S, Soldatos A, Toro C, Zein W, Snow J, Lehky T Semin Pediatr Neurol. 2024; 52():101168.

PMID: 39622608 PMC: 11730025. DOI: 10.1016/j.spen.2024.101168.


The Use of an Organo-Selenium Peptide to Develop New Antimicrobials That Target a Specific Bacteria.

Tran P, Kopel J, Fralick J, Reid T Antibiotics (Basel). 2021; 10(6).

PMID: 34063816 PMC: 8224008. DOI: 10.3390/antibiotics10060611.


Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.

Bowen W, Batra L, Pulsifer A, Yolcu E, Lawrenz M, Shirwan H Vaccine. 2019; 37(38):5708-5716.

PMID: 31416643 PMC: 6773249. DOI: 10.1016/j.vaccine.2019.07.103.


Prioritizing therapeutic targets using patient-derived xenograft models.

Lodhia K, Hadley A, Haluska P, Scott C Biochim Biophys Acta. 2015; 1855(2):223-34.

PMID: 25783201 PMC: 4433556. DOI: 10.1016/j.bbcan.2015.03.002.


Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent.

Graham V, Hatch G, Bewley K, Steeds K, Lansley A, Bate S J Immunol Res. 2014; 2014:807564.

PMID: 25097863 PMC: 4109106. DOI: 10.1155/2014/807564.